Viveve Medical (NASDAQ:VIVE – Get Free Report) is anticipated to announce its resultson Friday, March 20th. Analysts expect the company to announce earnings of $0.01 per share and revenue of $12.00 million for the quarter.
Viveve Medical Stock Performance
Shares of VIVE stock opened at $0.00 on Thursday. Viveve Medical has a 52-week low of $0.00 and a 52-week high of $0.00.
Viveve Medical Company Profile
Viveve Medical, Inc is a medical technology company focused on the development and commercialization of non-invasive solutions for women’s intimate health. The company’s flagship offering, the Viveve System, employs proprietary cryogen-cooled monopolar radiofrequency energy to gently heat and remodel vaginal tissue. This technology is designed to address conditions such as vaginal laxity and associated symptoms, offering a single-treatment protocol that can be performed in a clinical setting without the need for anesthesia.
Regulatory clearances, including U.S.
Featured Articles
Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.
